I have wondered if you have been coaching Andrew (he did supply you with email address). With your quick response in support, I will go with my suspicions.
"PYC's CPP does NOT, as some have suggested, target cancer cells or normal cells"
Why bring this up at this stage?
Small molecule drugs that inhibit intra-cell disease targets aren't cell specific, they go to every cell in the body, yet they are on the market and are considered to play a valuable role in combating disease.
So why not wait and see how many boxes are ticked in further studies before you hit us with cell-targeting.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |